{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:32:22Z","timestamp":1791297142007,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2010,4,22]]},"DOI":"10.1038\/onc.2009.521","type":"journal-article","created":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T11:17:03Z","timestamp":1265023023000},"page":"2449-2456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation"],"prefix":"10.1038","volume":"29","author":[{"given":"P J","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Rieker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E V","family":"Sviderskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D C","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M D","family":"Oberst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Merlino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,1]]},"reference":[{"key":"BFonc2009521_CR1","first-page":"3239","volume":"47","author":"A Albini","year":"1987","unstructured":"Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM et al. (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239\u20133245.","journal-title":"Cancer Res"},{"key":"BFonc2009521_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1755-148X.2007.00433.x","volume":"21","author":"DC Bennett","year":"2008","unstructured":"Bennett DC . (2008). How to make a melanoma: what do we know of the primary clonal events? Pig Cell Melan Res 21: 27\u201338.","journal-title":"Pig Cell Melan Res"},{"key":"BFonc2009521_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrc2296","volume":"8","author":"BO Bodemann","year":"2008","unstructured":"Bodemann BO, White MA . (2008). Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat Rev 8: 133\u2013140.","journal-title":"Nat Rev"},{"key":"BFonc2009521_CR4","first-page":"6997","volume":"62","author":"MS Brose","year":"2002","unstructured":"Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R et al. (2002). BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res 62: 6997\u20137000.","journal-title":"Cancer Res"},{"key":"BFonc2009521_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2006.08.034","volume":"127","author":"Y Chien","year":"2006","unstructured":"Chien Y, Kim S, Bumeister R, Loo YM, Kwon SW, Johnson CL et al. (2006). RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 127: 157\u2013170.","journal-title":"Cell"},{"key":"BFonc2009521_CR6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/sj.embor.embor899","volume":"4","author":"Y Chien","year":"2003","unstructured":"Chien Y, White MA . (2003). RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep 4: 800\u2013806.","journal-title":"EMBO Rep"},{"key":"BFonc2009521_CR7","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1101\/gad.1437206","volume":"20","author":"L Chin","year":"2006","unstructured":"Chin L, Garraway LA, Fisher DE . (2006). Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev 20: 2149\u20132182.","journal-title":"Genes Dev"},{"key":"BFonc2009521_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/ng1586","volume":"37","author":"Y Chudnovsky","year":"2005","unstructured":"Chudnovsky Y, Adams AE, Robbins PB, Lin Q, Khavari PA . (2005). Use of human tissue to assess the oncogenic activity of melanoma-associated mutations. Nat Genet 37: 745\u2013749.","journal-title":"Nat Genet"},{"key":"BFonc2009521_CR9","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMoa050092","volume":"353","author":"JA Curtin","year":"2005","unstructured":"Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H et al. (2005). Distinct sets of genetic alterations in melanoma. New Engl J Med 353: 2135\u20132147.","journal-title":"New Engl J Med"},{"key":"BFonc2009521_CR10","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/j.1600-0463.2007.apm_855.xml.x","volume":"115","author":"C Dahl","year":"2007","unstructured":"Dahl C, Guldberg P . (2007). The genome and epigenome of malignant melanoma. APMIS 115: 1161\u20131176.","journal-title":"APMIS"},{"key":"BFonc2009521_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/ng.356","volume":"41","author":"D Dankort","year":"2009","unstructured":"Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, Damsky Jr WE et al. (2009). Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet 41: 544\u2013552.","journal-title":"Nat Genet"},{"key":"BFonc2009521_CR12","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. (2002). Mutations of the BRAF gene in human cancer. Nature 417: 949\u2013954.","journal-title":"Nature"},{"key":"BFonc2009521_CR13","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1182\/blood-2007-08-106583","volume":"111","author":"DJ de Gorter","year":"2008","unstructured":"de Gorter DJ, Reijmers RM, Beuling EA, Naber HP, Kuil A, Kersten MJ et al. (2008). The small GTPase Ral mediates SDF-1-induced migration of B cells and multiple myeloma cells. Blood 111: 3364\u20133372.","journal-title":"Blood"},{"key":"BFonc2009521_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc969","volume":"3","author":"J Downward","year":"2003","unstructured":"Downward J . (2003). Targeting RAS signalling pathways in cancer therapy. Nat Rev 3: 11\u201322.","journal-title":"Nat Rev"},{"key":"BFonc2009521_CR15","doi-asserted-by":"publisher","first-page":"9483","DOI":"10.1158\/0008-5472.CAN-05-4227","volume":"66","author":"N Dumaz","year":"2006","unstructured":"Dumaz N, Hayward R, Martin J, Ogilvie L, Hedley D, Curtin JA et al. (2006). In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling. Cancer Res 66: 9483\u20139491.","journal-title":"Cancer Res"},{"key":"BFonc2009521_CR16","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1128\/MCB.00057-07","volume":"27","author":"SC Falsetti","year":"2007","unstructured":"Falsetti SC, Wang DA, Peng H, Carrico D, Cox AD, Der CJ et al. (2007). Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth. Mol Cell Biol 27: 8003\u20138014.","journal-title":"Mol Cell Biol"},{"key":"BFonc2009521_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0962-8924(03)00152-1","volume":"13","author":"LA Feig","year":"2003","unstructured":"Feig LA . (2003). Ral-GTPases: approaching their 15 minutes of fame. Trends Cell Biol 13: 419\u2013425.","journal-title":"Trends Cell Biol"},{"key":"BFonc2009521_CR18","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/jnci\/djn157","volume":"100","author":"DE Freedberg","year":"2008","unstructured":"Freedberg DE, Rigas SH, Russak J, Gai W, Kaplow M, Osman I et al. (2008). Frequent p16-independent inactivation of p14ARF in human melanoma. J Natl Cancer Inst 100: 784\u2013795.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2009521_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/sj.jid.5700026","volume":"126","author":"VK Goel","year":"2006","unstructured":"Goel VK, Lazar AJ, Warneke CL, Redston MS, Haluska FG . (2006). Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma. J Invest Derm 126: 154\u2013160.","journal-title":"J Invest Derm"},{"key":"BFonc2009521_CR20","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nature05661","volume":"445","author":"V Gray-Schopfer","year":"2007","unstructured":"Gray-Schopfer V, Wellbrock C, Marais R . (2007). Melanoma biology and new targeted therapy. Nature 445: 851\u2013857.","journal-title":"Nature"},{"key":"BFonc2009521_CR21","doi-asserted-by":"publisher","first-page":"10968","DOI":"10.1073\/pnas.0611638104","volume":"104","author":"L Ha","year":"2007","unstructured":"Ha L, Ichikawa T, Anver M, Dickins R, Lowe S, Sharpless NE et al. (2007). ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence. Proc Natl Acad Sci USA 104: 10968\u201310973.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009521_CR22","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1101\/gad.993902","volume":"16","author":"NM Hamad","year":"2002","unstructured":"Hamad NM, Elconin JH, Karnoub AE, Bai W, Rich JN, Abraham RT et al. (2002). Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev 16: 2045\u20132057.","journal-title":"Genes Dev"},{"key":"BFonc2009521_CR23","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1128\/MCB.10.6.2503","volume":"10","author":"G Heidecker","year":"1990","unstructured":"Heidecker G, Huleihel M, Cleveland JL, Kolch W, Beck TW, Lloyd P et al. (1990). Mutational activation of c-raf-1 and definition of the minimal transforming sequence. Mol Cell Biol 10: 2503\u20132512.","journal-title":"Mol Cell Biol"},{"key":"BFonc2009521_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ccr.2005.04.030","volume":"7","author":"KH Lim","year":"2005","unstructured":"Lim KH, Baines AT, Fiordalisi JJ, Shipitsin M, Feig LA, Cox AD et al. (2005). Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 7: 533\u2013545.","journal-title":"Cancer Cell"},{"key":"BFonc2009521_CR25","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1016\/j.cub.2006.10.023","volume":"16","author":"KH Lim","year":"2006","unstructured":"Lim KH, O'Hayer K, Adam SJ, Kendall SD, Campbell PM, Der CJ et al. (2006). Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr Biol 16: 2385\u20132394.","journal-title":"Curr Biol"},{"key":"BFonc2009521_CR26","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nature03890","volume":"436","author":"C Michaloglou","year":"2005","unstructured":"Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM et al. (2005). BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720\u2013724.","journal-title":"Nature"},{"key":"BFonc2009521_CR27","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/CMR.0b013e3282ef4178","volume":"17","author":"K Omholt","year":"2007","unstructured":"Omholt K, Hansson J . (2007). No evidence of RALGDS mutations in cutaneous melanoma. Melan Res 17: 410\u2013412.","journal-title":"Melan Res"},{"key":"BFonc2009521_CR28","doi-asserted-by":"publisher","first-page":"7111","DOI":"10.1158\/0008-5472.CAN-04-1957","volume":"65","author":"G Oxford","year":"2005","unstructured":"Oxford G, Owens CR, Titus BJ, Foreman TL, Herlevsen MC, Smith SC et al. (2005). RalA and RalB: antagonistic relatives in cancer cell migration. Cancer Res 65: 7111\u20137120.","journal-title":"Cancer Res"},{"key":"BFonc2009521_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng1054","volume":"33","author":"PM Pollock","year":"2003","unstructured":"Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM et al. (2003). High frequency of BRAF mutations in nevi. Nat Genet 33: 19\u201320.","journal-title":"Nat Genet"},{"key":"BFonc2009521_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1535-6108(02)00089-2","volume":"2","author":"PM Pollock","year":"2002","unstructured":"Pollock PM, Meltzer PS . (2002). A genome-based strategy uncovers frequent BRAF mutations in melanoma. Cancer Cell 2: 5\u20137.","journal-title":"Cancer Cell"},{"key":"BFonc2009521_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ccr.2004.07.009","volume":"6","author":"A Rangarajan","year":"2004","unstructured":"Rangarajan A, Hong SJ, Gifford A, Weinberg RA . (2004). Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6: 171\u2013183.","journal-title":"Cancer Cell"},{"key":"BFonc2009521_CR32","first-page":"6724","volume":"62","author":"JA Recio","year":"2002","unstructured":"Recio JA, Noonan FP, Takayama H, Anver MR, Duray P, Rush WL et al. (2002). Ink4a\/arf deficiency promotes ultraviolet radiation-induced melanomagenesis. Cancer Res 62: 6724\u20136730.","journal-title":"Cancer Res"},{"key":"BFonc2009521_CR33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1128\/MCB.26.2.727-734.2006","volume":"26","author":"C Rosse","year":"2006","unstructured":"Rosse C, Hatzoglou A, Parrini MC, White MA, Chavrier P, Camonis J . (2006). RalB mobilizes the exocyst to drive cell migration. Mol Cell Biol 26: 727\u2013734.","journal-title":"Mol Cell Biol"},{"key":"BFonc2009521_CR34","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1158\/1078-0432.CCR-06-2419","volume":"13","author":"SC Smith","year":"2007","unstructured":"Smith SC, Oxford G, Baras AS, Owens C, Havaleshko D, Brautigan DL et al. (2007). Expression of ral GTPases, their effectors, and activators in human bladder cancer. Clin Cancer Res 13: 3803\u20133813.","journal-title":"Clin Cancer Res"},{"key":"BFonc2009521_CR35","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.biocel.2008.09.022","volume":"41","author":"BL Stiles","year":"2009","unstructured":"Stiles BL . (2009). Phosphatase and tensin homologue deleted on chromosome 10: extending its PTENtacles. Internatl J Biochem Cell Biol 41: 757\u2013761.","journal-title":"Internatl J Biochem Cell Biol"},{"key":"BFonc2009521_CR36","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1038\/sj.onc.1201881","volume":"16","author":"H Tsao","year":"1998","unstructured":"Tsao H, Zhang X, Benoit E, Haluska FG . (1998). Identification of PTEN\/MMAC1 alterations in uncultured melanomas and melanoma cell lines. Oncogene 16: 3397\u20133402.","journal-title":"Oncogene"},{"key":"BFonc2009521_CR37","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/j.1460-2075.1996.tb00416.x","volume":"15","author":"T Urano","year":"1996","unstructured":"Urano T, Emkey R, Feig LA . (1996). Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J 15: 810\u2013816.","journal-title":"EMBO J"},{"key":"BFonc2009521_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1006\/abio.1999.4090","volume":"270","author":"VM Virador","year":"1999","unstructured":"Virador VM, Kobayashi N, Matsunaga J, Hearing VJ . (1999). A standardized protocol for assessing regulators of pigmentation. Anal Biochem 270: 207\u2013219.","journal-title":"Anal Biochem"},{"key":"BFonc2009521_CR39","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1158\/0008-5472.CAN-03-3433","volume":"64","author":"C Wellbrock","year":"2004","unstructured":"Wellbrock C, Ogilvie L, Hedley D, Karasarides M, Martin J, Niculescu-Duvaz D et al. (2004). V599EB-RAF is an oncogene in melanocytes. Cancer Res 64: 2338\u20132342.","journal-title":"Cancer Res"},{"key":"BFonc2009521_CR40","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1038\/sj.onc.1206451","volume":"22","author":"H Wu","year":"2003","unstructured":"Wu H, Goel V, Haluska FG . (2003). PTEN signaling pathways in melanoma. Oncogene 22: 3113\u20133122.","journal-title":"Oncogene"},{"key":"BFonc2009521_CR41","doi-asserted-by":"publisher","first-page":"7538","DOI":"10.1128\/MCB.00955-07","volume":"27","author":"J Yin","year":"2007","unstructured":"Yin J, Pollock C, Tracy K, Chock M, Martin P, Oberst M et al. (2007). Activation of the RalGEF\/Ral pathway promotes prostate cancer metastasis to bone. Mol Cell Biol 27: 7538\u20137550.","journal-title":"Mol Cell Biol"}],"updated-by":[{"DOI":"10.1038\/onc.2011.65","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T00:00:00Z","timestamp":1302739200000}}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2009521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009521","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T17:27:54Z","timestamp":1647883674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2009521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,1]]},"references-count":41,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2010,4,22]]}},"alternative-id":["BFonc2009521"],"URL":"https:\/\/doi.org\/10.1038\/onc.2009.521","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/onc.2011.65","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,1]]},"assertion":[{"value":"25 June 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}